SecBot SecBot
SECBOTREPLAY Home › Report › AZN

AZN · AstraZeneca filed a routine 6-K reporting the admission of 14,784…

ASTRAZENECA PLC · 6-K filed Jul 1, 2026 at 10:10 ET

At the news

NEUTRALIMPACT 2/10

6-K filed Jul 1, 2026 at 10:10 ET

AstraZeneca filed a routine 6-K reporting the admission of 14,784 ordinary shares issued under employee share schemes during June 2026. The new shares represent ~0.001% dilution to the 1.55B shares outstanding, immaterial and administrative in nature.

  • 14,784 ordinary shares of $0.25 each were admitted to trading on the London Stock Exchange Main Market
  • Shares were issued under employee share schemes between June 1 and June 30, 2026
  • Total shares outstanding post-admission: 1,551,024,534
  • New shares are fully fungible with existing ordinary shares (ISIN: GB0009895292)

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access